These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 34093205)
1. Identification of Docetaxel as a Potential Drug to Promote HDL Biogenesis. Choi HY; Ruel I; Genest J Front Pharmacol; 2021; 12():679456. PubMed ID: 34093205 [No Abstract] [Full Text] [Related]
5. Membrane microdomains and the regulation of HDL biogenesis. Genest J; Schwertani A; Choi HY Curr Opin Lipidol; 2018 Feb; 29(1):36-41. PubMed ID: 29135688 [TBL] [Abstract][Full Text] [Related]
6. HDLs and the pathogenesis of atherosclerosis. Schwertani A; Choi HY; Genest J Curr Opin Cardiol; 2018 May; 33(3):311-316. PubMed ID: 29561322 [TBL] [Abstract][Full Text] [Related]
7. Identification of an ABCA1-dependent phospholipid-rich plasma membrane apolipoprotein A-I binding site for nascent HDL formation: implications for current models of HDL biogenesis. Hassan HH; Denis M; Lee DY; Iatan I; Nyholt D; Ruel I; Krimbou L; Genest J J Lipid Res; 2007 Nov; 48(11):2428-42. PubMed ID: 17656736 [TBL] [Abstract][Full Text] [Related]
8. Natural human apoA-I mutations L141RPisa and L159RFIN alter HDL structure and functionality and promote atherosclerosis development in mice. Tiniakou I; Kanaki Z; Georgopoulos S; Chroni A; Van Eck M; Fotakis P; Zannis VI; Kardassis D Atherosclerosis; 2015 Nov; 243(1):77-85. PubMed ID: 26363436 [TBL] [Abstract][Full Text] [Related]
10. Role of apoA-I, ABCA1, LCAT, and SR-BI in the biogenesis of HDL. Zannis VI; Chroni A; Krieger M J Mol Med (Berl); 2006 Apr; 84(4):276-94. PubMed ID: 16501936 [TBL] [Abstract][Full Text] [Related]
11. Discrete roles of apoA-I and apoE in the biogenesis of HDL species: lessons learned from gene transfer studies in different mouse models. Zannis VI; Koukos G; Drosatos K; Vezeridis A; Zanni EE; Kypreos KE; Chroni A Ann Med; 2008; 40 Suppl 1():14-28. PubMed ID: 18246469 [TBL] [Abstract][Full Text] [Related]
12. A Systematic Investigation of Structure/Function Requirements for the Apolipoprotein A-I/Lecithin Cholesterol Acyltransferase Interaction Loop of High-density Lipoprotein. Gu X; Wu Z; Huang Y; Wagner MA; Baleanu-Gogonea C; Mehl RA; Buffa JA; DiDonato AJ; Hazen LB; Fox PL; Gogonea V; Parks JS; DiDonato JA; Hazen SL J Biol Chem; 2016 Mar; 291(12):6386-95. PubMed ID: 26797122 [TBL] [Abstract][Full Text] [Related]
13. The central helices of ApoA-I can promote ATP-binding cassette transporter A1 (ABCA1)-mediated lipid efflux. Amino acid residues 220-231 of the wild-type ApoA-I are required for lipid efflux in vitro and high density lipoprotein formation in vivo. Chroni A; Liu T; Gorshkova I; Kan HY; Uehara Y; Von Eckardstein A; Zannis VI J Biol Chem; 2003 Feb; 278(9):6719-30. PubMed ID: 12488454 [TBL] [Abstract][Full Text] [Related]
14. Deletion of the propeptide of apolipoprotein A-I reduces protein expression but stimulates effective conversion of prebeta-high density lipoprotein to alpha-high density lipoprotein. Sviridov D; Pyle LE; Jauhiainen M; Ehnholm C; Fidge NH J Lipid Res; 2000 Nov; 41(11):1872-82. PubMed ID: 11060357 [TBL] [Abstract][Full Text] [Related]
15. Adiponectin's mechanisms in high-density lipoprotein biogenesis and cholesterol efflux. Hafiane A; Daskalopoulou SS Metabolism; 2020 Dec; 113():154393. PubMed ID: 33058851 [TBL] [Abstract][Full Text] [Related]
16. Increased atherosclerosis in mice lacking apolipoprotein A-I attributable to both impaired reverse cholesterol transport and increased inflammation. Moore RE; Navab M; Millar JS; Zimetti F; Hama S; Rothblat GH; Rader DJ Circ Res; 2005 Oct; 97(8):763-71. PubMed ID: 16151025 [TBL] [Abstract][Full Text] [Related]
17. Deletion of amino acids Glu146-->Arg160 in human apolipoprotein A-I (ApoA-ISeattle) alters lecithin:cholesterol acyltransferase activity and recruitment of cell phospholipid. Lindholm EM; Bielicki JK; Curtiss LK; Rubin EM; Forte TM Biochemistry; 1998 Apr; 37(14):4863-8. PubMed ID: 9538003 [TBL] [Abstract][Full Text] [Related]
18. [Role of apolipoprotein AI on nascent high-density lipoprotein particle formation]. Wu JF; Tang YY; Zeng GF; Tang CK Sheng Li Ke Xue Jin Zhan; 2014 Apr; 45(2):81-6. PubMed ID: 25069300 [TBL] [Abstract][Full Text] [Related]
19. High-density lipoprotein and atherosclerosis: Roles of lipid transporters. Uehara Y; Saku K World J Cardiol; 2014 Oct; 6(10):1049-59. PubMed ID: 25349649 [TBL] [Abstract][Full Text] [Related]